Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Panel Gives Mixed Reviews To Using Single Trial For Community-Acquired Pneumonia

Related Content

Onyx Sees Blockbuster In Oncology Drug Carflizomib, Buys Proteolix To Get It

Oct 12 2009

Former FDA Director: Pneumonia Standards May Be Tough To Follow In Real World R&D

Sep 15 2009

Geron Gets Green Light To Test Embryonic Stem Cell Therapy On Humans

Jan 26 2009

Herbalife Proposes FDA Use NDI Master Files To Reduce Notification Burden

Oct 17 2011

Orphan Products Mostly Approved With Regulatory Flexibility, NORD "Catalog" Finds

Oct 17 2011

Bromday Battle Broadens: Ocular Drug Infection Risks, Fill Size Limits Will Get FDA Cmte. Scrutiny

Nov 16 2011

Pfizer Seeking Medco’s “Real World Data” For Targeted Therapy Development

Nov 07 2011

Phased Rx Drug Approval In Europe Could Help Switches – EU Execs

Nov 07 2011

CMS Sets The Stage For New Medicare "Coverage With Evidence Development" Guidance

Nov 08 2011

Panel Supports Symptoms-Based Endpoint For Community-Acquired Bacterial Pneumonia

Nov 03 2011

Rx Class Action Suits May Come To France In Response To Mediator Scandal

Nov 02 2011

CV Safety Requirements For Motility Drugs Could Take Indication-Centric Approach

Nov 15 2011

FDA Indicates Flexibility On Evidence To Support Efficacy In Pneumonia

Nov 01 2011

Prior Antibiotic Use A Necessary Confounder In Pneumonia Trials, Panel Says

Nov 14 2011

Prevnar 13 In Older Adults Appears To Have Smooth Path To FDA Approval

Nov 14 2011

Panel To Help Define Target Population For Xifaxan Reuse In IBS-D

Nov 14 2011

Adverse Events, Direct From The Consumer

Nov 14 2011

AstraZeneca, HealthCore Launch Outcomes Data Project, Seek Multi-Stakeholder Consortium

Feb 03 2011

FDA List Of Potential Safety Signals Has 3 Pfizer Drugs, Echoes Drug Watch Site

Sep 08 2008

Lucentis And Avastin Stack Up In CATT, Forcing Genentech/Novartis To Play Defense

Apr 28 2011

Generic Firms Get Supreme Shield From Product Liability, But Court Hints At Reg Change

Jun 23 2011

Incyte's Grip On Myelofibrosis Tightens With Release Of Positive JAK Data, FDA Filing

Jun 07 2011

Health IT The Linchpin To Health Care Reform – Bipartisan Policy Center

Jun 13 2011

Preparing For A Pricing Shift: Roche Admits Cost Is An Issue In Oncology And Beyond

Jun 27 2011

Medical Groups Call For More Flexibility, Time In EHR Stage 2 Meaningful Use

Mar 07 2011

PCORI Should Consider Health IT In Setting Research Priorities – Board’s Weisman

Sep 26 2011

Drug Recalls Will Be Announced Without Classification Under FDA Pilot

Sep 26 2011

Guidance In The Works For Unmet Need In Serious Bacterial Infections

Sep 26 2011

Sell The Launch: Going Commercial, Some Biotechs Are Left Hanging

Sep 05 2011

Orexigen Resurrects Contrave With New Trial Agreement With FDA

Sep 20 2011

Vertex's Next Steps Closely Watched Following Merck-Roche Deal On <i>Victrelis</i>

May 23 2011

FDA Advertising Studies Move Forward Along Several Broad Fronts

May 02 2011

FDA's Internet Promotion Policy: Christmas Cards In Lieu Of Guidance?

Jan 03 2011

FDA Publishes Small Entity Guide For Supplement GMPs

Dec 20 2010

Deals Of The Week: Cephalon/Mesoblast; GSK/MeiRui; Geron/Angiochem…

Dec 13 2010

Hospital-Acquired Pneumonia Is Life Or Death, FDA Says; Recommends Sole Primary Endpoint

Dec 07 2010

Senate Supplement Hearing Spotlights Self-Regulation, FDA Enforcement

May 31 2010

China's Outsource Sales Model Takes A Big Step: SciClone Takes Out NovaMed

Apr 19 2011

Invida Charts 25% Growth Plan, Banking On Selective Partnerships For High-value Products

Mar 25 2011

After A Record Year, China Healthcare IPOs Have Endured A Tough 2011

Jul 06 2011

With Pfizer As Cornerstone Investor, Will Shanghai Pharmaceutical Be Largest Pharma IPO Ever?

May 10 2011

Lilly To Buy Alnara And Its Non-Porcine Pancreatic Enzyme Replacement Therapy

Jul 02 2010

High Court’s Wyeth v. Levine Ruling Returns Pre-Emption Status Quo

Mar 09 2009

If States Win Lawsuits Against Health Reform Law, How Might Pharma Fare?

Oct 25 2010

Drug GMP Warning Letters, Enforcement Could Rebound in Obama's FDA

Apr 01 2009

INFORM-1 Data Show Potential Efficacy And Safety Of Roche HCV Combo

May 04 2009

As Some Pharma Companies Exit Facebook, Device Firms Stay Connected

Aug 22 2011

Avastin-Related Eye Infections Could Bring FDA Pressure On Compounding Pharmacies

Aug 31 2011

As Pharma Falters, Shire Specialist Model Hits Sweet Spot

Aug 02 2011

Safety Concerns Over Larger Bottle For ISTA's Bromday Could Impact Other Eye Drugs

Aug 02 2011

Additional Topics

Clinical Trials Regulation Advisory Committees BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window